Tracking and Evaluation Core for Oklahoma Shared Clinical and Translational Resources
Official title: Tracking and Evaluation Core
Funded at University of Oklahoma Hlth Sciences Ctr · NIH-11406265 · Data updated 2026-11-12
A program that helps Oklahoma researchers improve clinical and translational projects by tracking progress and measuring outcomes.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Oklahoma Hlth Sciences Ctr NIH-funded |
| Lab location | 1 site (Oklahoma City, United States) |
| Project start | September 1, 2013 |
| Project end | June 30, 2028 |
| Funding year | 2026 |
| Award (this year) | $180,689 |
| NIH project number | 5U54GM104938-14 |
| Project ID | NIH-11406265 on NIH RePORTER |
Who could benefit from this research
✓Could help
This grant does not enroll patients directly; it supports the research infrastructure that could ultimately benefit patients through improved clinical translation.
✕Less likely to help
Patients will not participate in activities under this core, and no direct patient interventions are involved.
What this research studies
This grant funds an Evaluation Core that partners with OSCTR to monitor and improve core activities. It builds logic models, tracks program milestones, and provides evaluation services to guide strategic decisions. The core works with investigators and leaders to capture data on processes and outcomes, helping identify gaps and refine approaches for better patient-oriented research. The aim is to strengthen efficiency and impact across OSCTR programs and related large institutional grants.
Why it matters
Potential benefit: If successful, it could lead to clearer pathways for translating clinical research into practice and better use of resources to benefit patients.
How similar studies have gone: Evaluation cores have repeatedly demonstrated value in guiding large translational programs, improving efficiency and outcomes.
Where this research is happening
-
University of Oklahoma Hlth Sciences Ctr
Oklahoma City, United States Active
Researchers
- Principal investigator: Campbell, Janis E — University of Oklahoma Hlth Sciences Ctr
- Study coordinator: Campbell, Janis E
Related research
Other NIH-funded projects on the same topics.
-
Primary care research network in Oklahoma to boost rural patient trials
A nationwide NIH-supported effort to strengthen Oklahoma’s primary care research network so doctors can run big clinical trials and real‑world studies in rural communities.
-
N-myristoylation and DNA damage response in Alzheimer’s disease
A study to understand how a protein modification called myristoylation affects the DNA damage response in people who have Alzheimer’s-related conditions.
-
Genetically engineered mouse model to study and treat high-risk pediatric rhabdomyosarcoma
A research project aims to create mouse models that mimic high-risk pediatric rhabdomyosarcoma and test therapies that target the NOTCH1 pathway to slow or stop tumor growth.
-
Understanding how bone cancer cells rely on certain pathways to grow in childhood osteosarcoma
This grant studies how specific cancer-related pathways in bone-forming cells drive osteosarcoma in children, with the aim of finding better treatments.
-
Vascular signals from brain blood vessels influence immune-suppressing cells in glioblastoma
This grant explores how blood vessel cells in glioblastoma shape immune cells to help the tumor grow, with the aim of making immunotherapies work better for patients.
-
TFEB as a key switch to keep muscles healthy as we age
A study in aging adults and aging muscle tissues looks at whether boosting TFEB can improve how muscles maintain themselves and recover after disuse.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.